ProSpecBio has launched its latest product: CHO cell–derived recombinant Activin-A, now available for immediate delivery worldwide.  Activin-A is increasingly recognized as a potential therapeutic agent for conditions such as brain injury and inflammatory diseases.

https://www.businesswire.com/news/home/20250918856943/en/ProSpecBio-Launches-Activin-A-Recombinant-Protein-Empowering-Global-Research-in-Inflammation-and-Brain-Injury

https://www.prospecbio.com/

https://www.youtube.com/watch?v=623K0ta58gI